SecProbe.io

Filing text and metadata
Intelligence Terminal Search Probe Scores Topics IPO Watchlist Monthly Activity About API

SEC Comment Letter for DarioHealth Corp. (DRIO) (CIK 0001533998) (DRIO) — Mar 15, 2017

DarioHealth Corp. (DRIO) (CIK 0001533998)
Date: March 15, 2017 · CIK: 0001533998 · Accession: 0000000000-17-008509

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-216607

Date
March 10, 2017
Author
/s/ Amanda Ravitz
Form
UPLOAD
Company
DarioHealth Corp. (DRIO) (CIK 0001533998)

Letter

Mail Stop 3030 March 15 , 2017 Via E -mail Erez Raphael Chief Executive Officer DarioHealth Corp. 9 Halamish Street Caesarea Industrial Park 3088900, Israel

Re: DarioHealth Corp. Registration Statement on Form S-3 Filed March 10, 2017 File No. 333-216607

Dear Mr. Raphael :

Our preliminary review of your registration statement indicates that it fails in numerous material respects to comply with the requirements of the Securities Act of 1933, the rules and regulations under that Act, and the requirements of the form. In particular, your filing must be amended to present updated financial statements required by Rule 8 -08 of Regulation S -X. We will not perform a detailed examinatio n of the registration statement and we will not issue comments. We suggest that you consider filing a substantive amendment to correct the deficiencies.

If you were to request acceleration of the effective date of the registration statement in its present form, we would likely recommend that the Commission deny your request.

Sincerely,
/s/ Amanda Ravitz

Show Raw Text
Mail Stop 3030
March 15 , 2017

Via E -mail
Erez Raphael
Chief Executive Officer
DarioHealth Corp.
9 Halamish Street
Caesarea Industrial Park
3088900, Israel

Re: DarioHealth Corp.
 Registration Statement on Form S-3
 Filed  March 10, 2017
 File No.  333-216607

Dear Mr. Raphael :

Our preliminary review of your registration statement indicates that it fails in numerous
material respects to comply with the requirements of the Securities Act of 1933, the rules and
regulations under that Act, and the requirements of the form.  In particular, your filing must be
amended to present updated financial statements required by Rule 8 -08 of Regulation S -X.  We will
not perform a detailed examinatio n of the registration statement and we will not issue comments.
We suggest that you consider filing a substantive amendment to correct the deficiencies.

If you were to request acceleration of the effective date of the registration statement in its
present form, we would likely recommend that the Commission deny your request.

Sincerely,

 /s/ Amanda Ravitz

 Amanda Ravitz
Assistant Director
Office of Electronics and Machinery

cc:  Robert V. Condon III, Esq.
 Sullivan & Worcester LLP